Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-12-21
pubmed:abstractText
Pleiotropic, immunomodulatory effects of type I IFN on T cell responses are emerging. We used vaccine-induced, antiviral CD8(+) T cell responses in IFN-beta (IFN-beta(-/-))- or type I IFN receptor (IFNAR(-/-))-deficient mice to study immunomodulating effects of type I IFN that are not complicated by the interference of a concomitant virus infection. Compared with normal B6 mice, IFNAR(-/-) or IFN-beta(-/-) mice have normal numbers of CD4(+) and CD8(+) T cells, and CD25(+)FoxP3(+) T regulatory (T(R)) cells in liver and spleen. Twice as many CD8(+) T cells specific for different class I-restricted epitopes develop in IFNAR(-/-) or IFN-beta(-/-) mice than in normal animals after peptide- or DNA-based vaccination. IFN-gamma and TNF-alpha production and clonal expansion of specific CD8(+) T cells from normal and knockout mice are similar. CD25(+)FoxP3(+) T(R) cells down-modulate vaccine-primed CD8(+) T cell responses in normal, IFNAR(-/-), or IFN-beta(-/-) mice to a comparable extent. Low IFN-alpha or IFN-beta doses (500-10(3) U/mouse) down-modulate CD8(+) T cells priming in vivo. IFNAR- and IFN-beta-deficient mice generate 2- to 3-fold lower numbers of IL-10-producing CD4(+) T cells after polyclonal or specific stimulation in vitro or in vivo. CD8(+) T cell responses are thus subjected to negative control by both CD25(+)FoxP3(+) T(R) cells and CD4(+)IL-10(+) T(R1) cells, but only development of the latter T(R) cells depends on type I IFN.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
174
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
99-109
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:15611232-Adoptive Transfer, pubmed-meshheading:15611232-Animals, pubmed-meshheading:15611232-CD8-Positive T-Lymphocytes, pubmed-meshheading:15611232-DNA-Binding Proteins, pubmed-meshheading:15611232-Dendritic Cells, pubmed-meshheading:15611232-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:15611232-Forkhead Transcription Factors, pubmed-meshheading:15611232-Interferon Type I, pubmed-meshheading:15611232-Interferon-gamma, pubmed-meshheading:15611232-Interleukin-10, pubmed-meshheading:15611232-Liver, pubmed-meshheading:15611232-Lymphocyte Activation, pubmed-meshheading:15611232-Mice, pubmed-meshheading:15611232-Mice, Knockout, pubmed-meshheading:15611232-Receptors, Interferon, pubmed-meshheading:15611232-Receptors, Interleukin-2, pubmed-meshheading:15611232-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15611232-Spleen, pubmed-meshheading:15611232-Th1 Cells, pubmed-meshheading:15611232-Tumor Necrosis Factor-alpha
pubmed:year
2005
pubmed:articleTitle
Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells.
pubmed:affiliation
Department of Medical Microbiology and Immunology, University of Ulm, Helmholtzstrasse 8/1, D-89081 Ulm, Germany. nektarios.dikopoulos@medizin.uni-ulm.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't